Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

被引：60
|
作者：
Boissinot, Marjorie [1 ]
Lippert, Eric [1 ]
Girodon, Francois [1 ]
Dobo, Irene [1 ]
Fouassier, Marc [1 ]
Masliah, Claude [1 ]
Praloran, Vincent [1 ]
Hermouet, Sylvie [1 ]
机构：
[1] CHU Nantes, Lab Hematol, Inst Biol, F-44093 Nantes, France
来源：
BLOOD | 2006年 / 108卷 / 09期
关键词：
D O I：
10.1182/blood-2006-05-021527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3223 / 3224
页数：2
相关论文
共 50 条
  • [21] JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
    Demirkan, F.
    Kalkan, S.
    Kahraman, S.
    Tunali, S.
    Katgi, A.
    Piskin, O.
    Ozcan, M. A.
    Ozsan, H. G.
    Undar, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
  • [22] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
  • [23] Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
    Guy, Alexandre
    Danaee, Anicee
    Paschalaki, Koralia
    Boureau, Lisa
    Riviere, Etienne
    Etienne, Gabriel
    Mansier, Olivier
    Laffan, Michael
    Sekhar, Mallika
    James, Chloe
    HEMASPHERE, 2020, 4 (03):
  • [24] JAK2V617F Mutation in Patients with Portal Vein Thrombosis
    Yusuf Bayraktar
    Ozgur Harmanci
    Yahya Büyükasik
    Ali Ibrahim Shorbagi
    Aysegul Hasegeli Sungur
    Cemaliye Akyerli Boylu
    Aytemiz Gürgey
    Ferhun Balkanci
    Digestive Diseases and Sciences, 2008, 53 : 2778 - 2783
  • [25] JAK2V617F mutation in patients with portal vein thrombosis
    Bayraktar, Yusuf
    Harmanci, Ozgur
    Buyukasik, Yahya
    Shorbagi, Ali Ibrahim
    Sungur, Aysegul Hasegeli
    Boylu, Cemaliye Akyerli
    Gurgey, Aytemiz
    Balkanci, Ferhun
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (10) : 2778 - 2783
  • [26] JAK2-V617F Mutation in Patients with Myeloproliferative Neoplasms: Association with FLT3-ITD Mutation
    Spasovski, Vesna
    Tosic, Natasa
    Kostic, Tatjana
    Pavlovic, Sonja
    Colovic, Milica
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (9-10) : 614 - 618
  • [27] JAK2-V617F Mutation is Associated with Clinical and Laboratory Features of Myeloproliferative Neoplasms
    Duletic, Antica Nacinovic
    Dekanic, Andrea
    Hadzisejdic, Ita
    Kusen, Ivona
    Matusan-Llijas, Koviljka
    Grohovac, Dragana
    Grahovac, Blazenka
    Jonjic, Nives
    COLLEGIUM ANTROPOLOGICUM, 2012, 36 (03) : 859 - 865
  • [28] JAK2-V617F mutation is present in patients with idiopathic DVT
    Lauw, M. N.
    Bus, E. B.
    van Wulfften Palthe, A. F. Y.
    Homburg, C. H.
    Coppens, M.
    Middeldorp, S.
    van der Schoot, C. E.
    Koene, H. R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 125 - 126
  • [29] Insights into JAK2-V617F mutation in CML
    Buesche, Guntram
    Hussein, Kais
    Bock, Oliver
    Kreipe, Hans
    LANCET ONCOLOGY, 2007, 8 (10): : 863 - 864
  • [30] Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms
    Dong, Bingfei
    Zhang, Yang
    Fu, Xueqi
    Wang, Guangyi
    THROMBOSIS RESEARCH, 2012, 129 (05) : 664 - 665
12345